Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 21, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
15,000
Total Value
$275,773.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Jul 17, 2026 | Exercise/Conversion | 5,000 | $2.48 | $12,400.00 | 30,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 231 | $50.05 | $11,562.52 | 29,769 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 459 | $51.55 | $23,659.89 | 29,310 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 2,063 | $52.39 | $108,084.90 | 27,247 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 2,184 | $53.42 | $116,669.06 | 25,063 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 63 | $53.92 | $3,397.01 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Jul 17, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 116,268 | Direct | โ | View Details |